Skip to main content
. 2015 Dec 30;291(8):4128–4143. doi: 10.1074/jbc.M115.689620

FIGURE 9.

FIGURE 9.

Simplified pictorial representation of effects of myozap deficiency on cardiac signaling. Myozap deficiency on the one hand inhibits SRF signaling via inhibition of MAPK ERK1/2, RhoA, and MKL1. On the other hand, it activates prohypertrophic calcineurin-NFAT via inhibition of MAPK p38 and interconnected GSK-3β/β-catenin-driven signaling cascade in response to biomechanical stress. Cn, calcineurin; β-catn, β-catenin.